79.03
price up icon3.17%   2.4256
 
loading
前日終値:
$76.60
開ける:
$79.15
24時間の取引高:
727.70K
Relative Volume:
0.24
時価総額:
$10.32B
収益:
$638.78M
当期純損益:
$-22.66M
株価収益率:
-453.13
EPS:
-0.1744
ネットキャッシュフロー:
$122.18M
1週間 パフォーマンス:
+12.72%
1か月 パフォーマンス:
+21.36%
6か月 パフォーマンス:
+329.75%
1年 パフォーマンス:
+506.07%
1日の値動き範囲:
Value
$76.73
$80.11
1週間の範囲:
Value
$70.11
$80.11
52週間の値動き範囲:
Value
$11.16
$80.11

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1073)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,178
Name
Twitter
@10xgenomics
Name
次回の収益日
2026-11-05
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

Compare TXG vs VEEV, TEM, BTSG, HQY

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TXG icon
TXG
10 X Genomics Inc
79.19 8.94B 638.78M -22.66M 122.18M -0.1744
VEEV icon
VEEV
Veeva Systems Inc
258.19 42.48B 3.32B 941.65M 1.64B 5.6161
TEM icon
TEM
Tempus Ai Inc
77.55 10.71B 1.36B -302.91M -219.93M -1.7182
BTSG icon
BTSG
Brightspring Health Services Inc
56.81 11.62B 13.65B 169.86M 412.12M 1.0758
HQY icon
HQY
Healthequity Inc
94.69 7.96B 1.34B 230.70M 440.96M 2.6695

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-31 アップグレード William Blair Mkt Perform → Outperform
2025-12-11 ダウングレード Citigroup Buy → Neutral
2025-12-02 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-09-11 開始されました Piper Sandler Neutral
2025-02-13 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
Sep 12, 2026

Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia

Sep 12, 2026
pulisher
Sep 12, 2026

Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know - Yahoo Finance

Sep 12, 2026
pulisher
Sep 11, 2026

10x Genomics (TXG) CFO Adam Taich Sells 46,388 Shares - GuruFocus

Sep 11, 2026
pulisher
Sep 11, 2026

10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com Nigeria

Sep 11, 2026
pulisher
Sep 11, 2026

10x Genomics Inc (TXG) Shares Surge 3.3% -- What GF Score of 56 Tells Investors - GuruFocus

Sep 11, 2026
pulisher
Sep 11, 2026

10x Genomics (TXG) CFO sells shares under preset trading plan - Stock Titan

Sep 11, 2026
pulisher
Sep 11, 2026

10x Genomics CFO Adam Taich sells USD 2.99 million in common shares - Bitget

Sep 11, 2026
pulisher
Sep 10, 2026

10x Genomics to Use Lunit’s AI-Powered Pathology Platform for Oncology Biomarker Discovery - GenomeWeb

Sep 10, 2026
pulisher
Sep 10, 2026

AI will pair tissue scans with molecular maps in cancer studies - Stock Titan

Sep 10, 2026
pulisher
Sep 09, 2026

10x genomics director Stuelpnagel sells $1.2 million in shares By Investing.com - Investing.com Australia

Sep 09, 2026
pulisher
Sep 09, 2026

symbol__ Stock Quote Price and Forecast - CNN

Sep 09, 2026
pulisher
Sep 09, 2026

10x Genomics (NASDAQ: TXG) executive plans multimillion-dollar stock sale - Stock Titan

Sep 09, 2026
pulisher
Sep 09, 2026

10x Genomics Insider John R. Stuelpnagel Sells 20,000 Shares Between $60.66 and $62.61 on September 3, 2026 (NASDAQ: TXG) - kalkinemedia.com

Sep 09, 2026
pulisher
Sep 09, 2026

10x Genomics stock hits 52-week high at 66.95 USD By Investing.com - Investing.com South Africa

Sep 09, 2026
pulisher
Sep 09, 2026

Macrogen to offer 10x Genomics spatial biology platform in Asia first - Korea Biomedical Review

Sep 09, 2026
pulisher
Sep 08, 2026

10x genomics director Stuelpnagel sells $1.2 million in shares - investing.com

Sep 08, 2026
pulisher
Sep 08, 2026

10x Genomics Inc (TXG) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 56/100 - GuruFocus

Sep 08, 2026
pulisher
Sep 08, 2026

10x Genomics (TXG) director offloads 20,000 shares in open-market trades - Stock Titan

Sep 08, 2026
pulisher
Sep 08, 2026

T. Rowe Price reports 10%+ holding in 10x Genomics (TXG) - Stock Titan

Sep 08, 2026
pulisher
Sep 08, 2026

Stifel reiterates Buy rating on 10X Genomics stock - investing.com

Sep 08, 2026
pulisher
Sep 04, 2026

10X Genomics Inc (TXG) Key Financial Ratios – Valuation, Profitability & More - Value Research

Sep 04, 2026
pulisher
Sep 03, 2026

10x Genomics (TXG) CEO holds 1,075,249 shares after 100-share gift - Stock Titan

Sep 03, 2026
pulisher
Sep 03, 2026

Founder trust at 10x Genomics (NASDAQ: TXG) moves to sell 20,000 shares - Stock Titan

Sep 03, 2026
pulisher
Sep 03, 2026

10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead? - finance.yahoo.com

Sep 03, 2026
pulisher
Sep 02, 2026

TXG Stock Price and Chart — NASDAQ:TXG - TradingView

Sep 02, 2026
pulisher
Sep 01, 2026

A Look at 10x Genomics Inc (TXG) After 4.0% Decline -- GF Value $18.36 vs Price $60.00 - GuruFocus

Sep 01, 2026
pulisher
Sep 01, 2026

RBC Capital initiates 10X Genomics stock with Sector Perform rating - investing.com

Sep 01, 2026
pulisher
Sep 01, 2026

10X GENOMICS, INC. : RBC INITIATES COVERAGE WITH SECTOR PERFORM RATING; TARGET PRICE $70 - Bitget

Sep 01, 2026
pulisher
Aug 31, 2026

Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit - Benzinga

Aug 31, 2026
pulisher
Aug 31, 2026

TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

10X Genomics Inc (TXG) Peer Comparison – Compare with Others - Value Research

Aug 31, 2026
pulisher
Aug 31, 2026

10x Genomics Wins Patent Infringement Verdict against Parse Biosciences - marketscreener.com

Aug 31, 2026
pulisher
Aug 31, 2026

Delaware jury finds Parse infringed three genetic-sequencing patents - Reuters

Aug 31, 2026
pulisher
Aug 30, 2026

TXG - Finviz

Aug 30, 2026
pulisher
Aug 28, 2026

10x Genomics Inc (TXG) Shares Fall 5.1% -- GF Value Says Still O - GuruFocus

Aug 28, 2026
pulisher
Aug 28, 2026

10x Genomics (TXG) CEO sells 10,486 shares under 10b5-1 plan - Stock Titan

Aug 28, 2026
pulisher
Aug 28, 2026

10x Genomics wins jury award in Qiagen patent row (TXG:NASDAQ) - Seeking Alpha

Aug 28, 2026
pulisher
Aug 28, 2026

10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences - Porterville Recorder

Aug 28, 2026
pulisher
Aug 26, 2026

10x Genomics Inc (TXG) Director Shehnaaz Suliman Sells 2,207 Sha - GuruFocus

Aug 26, 2026
pulisher
Aug 26, 2026

10x Genomics (NASDAQ: TXG) CEO sells for taxes, still holds 1,085,835 shares - Stock Titan

Aug 26, 2026
pulisher
Aug 26, 2026

10x Genomics (NASDAQ: TXG) CEO lines up another share sale - Stock Titan

Aug 26, 2026
pulisher
Aug 24, 2026

10x Genomics (NASDAQ: TXG) exec to sell 16,614 shares - Stock Titan

Aug 24, 2026
pulisher
Aug 24, 2026

10x Genomics (NASDAQ: TXG) insider plans sale of 17,948 shares - Stock Titan

Aug 24, 2026
pulisher
Aug 24, 2026

10x Genomics (NASDAQ: TXG) holder to sell about $871K in stock - Stock Titan

Aug 24, 2026
pulisher
Aug 24, 2026

10x Genomics (TXG) CEO gifts 4,000 shares in stock donation - Stock Titan

Aug 24, 2026
pulisher
Aug 20, 2026

10x Genomics: The Turnaround Is Real, But Atera Now Has To Deliver (Rating Upgrade) (TXG) - Seeking Alpha

Aug 20, 2026
pulisher
Aug 19, 2026

Fed. Circ. Backs PTAB's Ax Of 10x Genomics Patent Claims - law360.com

Aug 19, 2026
pulisher
Aug 19, 2026

Federal Circuit Upholds PTAB Obviousness Rulings Against Single Cell Sequencing Patents - IPWatchdog.com

Aug 19, 2026
pulisher
Aug 19, 2026

10x Genomics Gains as Investors Extend Post-Earnings Rally on Atera Demand - Quiver Quantitative

Aug 19, 2026
pulisher
Aug 19, 2026

10x Genomics’ Bid to Revive Patents Rejected by Federal Circuit - Bloomberg Law News

Aug 19, 2026
pulisher
Aug 19, 2026

10x Genomics (NASDAQ:TXG) Reaches New 52-Week HighWhat's Next? - MarketBeat

Aug 19, 2026

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$56.68
price down icon 0.16%
HQY HQY
$94.75
price down icon 0.50%
$93.42
price down icon 1.42%
TEM TEM
$77.65
price down icon 0.40%
WAY WAY
$25.54
price down icon 0.51%
大文字化:     |  ボリューム (24 時間):